Informed by a scoping review of the literature, the purpose of this Request for Proposals (RFP) is to fund research studies that will increase our understanding of effective interventions for increasing accrual to therapeutic cancer clinical trials, particularly among underrepresented populations. Specifically, we seek proposals that will implement and evaluate interventions designed to a) mitigate multilevel barriers to therapeutic clinical trial accrual for underrepresented groups and b) quantitatively measure the impact of these interventions on patient accrual. We are particularly interested in proposals that address systemic, institutional, and clinician-related barriers that impede clinical trial participation.
Deadlines:
- Required Letter of Intent: Sep. 11, 2025
- Invited Full Application: Jan. 29, 2026
LLS welcomes Principal Investigators at all stages of their careers as well as Principal Investigators who have not previously conducted research in the area of blood cancer. However, if the Principal Investigator is an early investigator, a more experienced Co-Principal Investigator is required.
The Principal Investigator and other study team members may come from a variety of disciplines, including but not limited to medicine/oncology, nursing, social work, public health, health services research, economics, sociology, health communication, epidemiology, and biostatistics. We strongly encourage multi-disciplinary teams.
Maximum project period is 5 years, and the maximum funding amount per year is $500,000.